Clinical management of low ovarian response to stimulation for IVF: a systematic review
The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Poor response is not a rare occurrence in ovarian stimulation. Although not fully accepted, the most dominant criteria for poor ovarian response are small numbers of follicles developed or oocytes retrieved, and low estradiol (E2) levels after the use of a standard stimulation protocol. There is no ideal predictive test as the poor responder is revealed only during ovulation induction; however, increased levels of day 3 FSH and E2 as well as decreased levels of inhibin B can be used to assess ovarian reserve. Several protocols have been proposed for clinical management of low ovarian response in IVF. Although high doses of gonadotrophins have been used by the vast majority of authors, results have been controversial and prospective randomized studies have shown little or no benefit. The few available relevant studies do not indicate that recombinant FSH improves outcome. Flare-up GnRH agonist protocols (including all dosage varieties) produce better results than standard long luteal protocols. Luteal initiation GnRH agonist 'stop' protocols were shown to improve ovarian response according to prospective studies with historical controls, but this was not confirmed by well-designed prospective, randomized, controlled studies. The few available data obtained with GnRH antagonists have not shown any benefits. Adjuvant therapy with growth hormone (GH) or GH-releasing factors results in no significant improvement. The use of corticosteroids reduces the incidence of poor ovarian response in women undergoing IVF treatment. The limited data obtained with nitric oxide donors are encouraging. Pretreatment with combined oral contraceptives prior to stimulation may help ovarian response. No benefit was observed with standard use of ICSI or assisted hatching of zona pellucida. Finally, natural cycle IVF has produced results which are comparable with those obtained with stimulated cycles in true poor responders. Well-designed, large-scale, randomized, controlled trials are needed to assess the efficacy of these different management strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitric oxide: physiology, pathophysiology, and pharmacology.
Moncada, S., Palmer, R. M., & Higgs, E. A. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06663-3 · Cited by 15,525
Regulation of ovarian follicular development in primates: facts and hypotheses
GOUGEON, A. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-2-121 · Cited by 1,497
Antimüllerian hormone serum levels: a putative marker for ovarian aging
de Vet, A., Laven, J. S. E., de Jong, F. H., Themmen, A. P. N., & Fauser, B. C. J. M. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)02993-4 · Cited by 887
Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome
Scott, R. T., Toner, J. P., Muasher, S. J., Oehninger, S., Robinson, S., & Rosenwaks, Z. (1989) · Fertility and Sterility · doi:10.1016/s0015-0282(16)60615-5 · Cited by 569
Toner, J. P., Philput, C. B., Jones, G. S., & Muasher, S. J. (1991) · Fertility and Sterility · doi:10.1016/s0015-0282(16)54249-6 · Cited by 496
Bancsi, L. F. J. M. M., Broekmans, F. J. M., Eijkemans, M. J. C., de Jong, F. H., Habbema, J. D. F., & te Velde, E. R. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)02983-1 · Cited by 441
Cohen, J., Alikani, M., Trowbridge, J., & Rosenwaks, Z. (1992) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a137720 · Cited by 413
Studying the Natural History of Back Pain
Korff, M. V. (1994) · Spine · doi:10.1097/00007632-199409151-00005 · Cited by 405
PROGNOSTIC ASSESSMENT OF FEMALE FECUNDITY
Navot, D., Rosenwaks, Z., & Margalioth, E. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92439-1 · Cited by 391
Use of the Antral Follicle Count to Predict the Outcome of Assisted Reproductive Technologies
Chang, M.-Y., Chiang, C.-H., Hsieh, T.-T., Soong, Y.-K., & Hsu, K.-H. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(97)00557-8 · Cited by 327
Cited by
Ferraretti, A. P., La Marca, A., Fauser, B. C. J. M., Tarlatzis, B., Nargund, G., Gianaroli, L., & on behalf of the ESHRE working group on Poor Ovarian Response Definition (2011) · Human Reproduction · doi:10.1093/humrep/der092 · Cited by 1,882
Self-citationA systematic review of tests predicting ovarian reserve and IVF outcome
Broekmans, F. J., Kwee, J., Hendriks, D. J., Mol, B. W., & Lambalk, C. B. (2006) · Human Reproduction Update · doi:10.1093/humupd/dml034 · Cited by 1,258
Ovarian aging: mechanisms and clinical consequences
Broekmans, F. J., Soules, M. R., & Fauser, B. C. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0006 · Cited by 1,248
Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)
La Marca, A., Sighinolfi, G., Radi, D., Argento, C., Baraldi, E., Artenisio, A. C., Stabile, G., & Volpe, A. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmp036 · Cited by 956
The Science behind 25 Years of Ovarian Stimulation for in Vitro Fertilization
Macklon, N. S., Stouffer, R. L., Giudice, L. C., & Fauser, B. C. J. M. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0015 · Cited by 562
Broer, S. L., Mol, B. W. J., Hendriks, D., & Broekmans, F. J. M. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.12.013 · Cited by 546
Broer, S. L., van Disseldorp, J., Broeze, K. A., Dolleman, M., Opmeer, B. C., Bossuyt, P., Eijkemans, M. J. C., Mol, B.-W. J., Broekmans, F. J. M., on behalf of the IMPORT study group, et al. (2013) · Human Reproduction Update · doi:10.1093/humupd/dms041 · Cited by 457
Nelson, S. M., Yates, R. W., & Fleming, R. (2007) · Human Reproduction · doi:10.1093/humrep/dem204 · Cited by 391
Goswami, S. K. (2004) · Human Reproduction · doi:10.1093/humrep/deh359 · Cited by 372
“Various protocols of ovarian stimulation have been proposed for optimizing IVF results in the poorly responding women (Tarlatzis et al., 2003); however, good response to stimulation still remains a challenge.”
BackgroundAnti-Mullerian hormone-based approach to controlled ovarian stimulation for assisted conception
Nelson, S. M., Yates, R. W., Lyall, H., Jamieson, M., Traynor, I., Gaudoin, M., Mitchell, P., Ambrose, P., & Fleming, R. (2008) · Human Reproduction · doi:10.1093/humrep/den480 · Cited by 339
Hohmann, F. P., Macklon, N. S., & Fauser, B. C. J. M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020788 · Cited by 281
Grynberg, M., Fanchin, R., Dubost, G., Colau, J.-C., Brémont-Weil, C., Frydman, R., & Ayoubi, J.-M. (2010) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2009.12.021 · Cited by 256
Female and male lifestyle habits and IVF: what is known and unknown
Klonoff-Cohen, H. (2005) · Human Reproduction Update · doi:10.1093/humupd/dmh059 · Cited by 173
Bosdou, J. K., Venetis, C. A., Kolibianakis, E. M., Toulis, K. A., Goulis, D. G., Zepiridis, L., & Tarlatzis, B. C. (2012) · Human Reproduction Update · doi:10.1093/humupd/dmr051 · Cited by 141
Self-citationAndrogens and ovarian function: translation from basic discovery research to clinical impact
Walters, K. A., Rodriguez Paris, V, Aflatounian, A., & Handelsman, D. J. (2019) · Journal of Endocrinology · doi:10.1530/joe-19-0096 · Cited by 104
Fabregues, F., González-Foruria, I., Peñarrubia, J., & Carmona, F. (2018) · Human Reproduction · doi:10.1093/humrep/dey244 · Cited by 34
Metadata
- Authors
- Tarlatzis, B. C.
- Venue
- Human Reproduction Update
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-01-01
- Volume
- 9
- Issue
- 1
- Pages
- 61-76
- ISSN
- 1355-4786 (ISSN-L)
- 1460-2369
- OpenAlex
- W2146085625
- Cited by
- 365
- References
- 58
- FWCI
- 17.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.